NCT01950936View on ClinicalTrials.gov

Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Chronic Obstructive Lung Disease
Interventions
OTHER

Discontinuation of Antibiotcs

Discontinuation of Antibiotcs against lower respiratory tract infections

Trial Locations (1)

DK-2400

Dept. of Pulmonary Medicine, Copenhagen NV

All Listed Sponsors
collaborator

Copenhagen University Hospital, Denmark

OTHER

lead

Danish Procalcitonin Study Group

OTHER

NCT01950936 - Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD) | Biotech Hunter | Biotech Hunter